CS
VERA icon

Credit Suisse’s Vera Therapeutics VERA Stock Holding History

Credit Suisse’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.22M Buy
28,254
+8,317
+42% +$296K ﹤0.01% 2149
2023
Q4 		$307K Buy
19,937
+4,014
+25% +$51K ﹤0.01% 2908
2023
Q3 		$218K Buy
+15,923
New +$273K ﹤0.01% 3010
2023
Q1 		– Sell
-9,558
Closed -$185K – 3732
2022
Q4 		$185K Sell
9,558
-109
-1% -$1.97K ﹤0.01% 3206
2022
Q3 		$207K Buy
9,667
+63
+0.7% +$1.18K ﹤0.01% 3231
2022
Q2 		$131K Buy
+9,604
New +$168K ﹤0.01% 3468

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse's VERA Position: Q1 2024 in Review

Credit Suisse increased its Vera Therapeutics (VERA) stake by 42% in Q1 2024, buying an estimated $296K and bringing the position to 28,254 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2149.

Credit Suisse first reported a position in VERA in Q2 2022 and has held it in 6 quarters since. 160 funds tracked by Wall St. Rank hold VERA as of Q1 2024.

  • Credit Suisse held 28,254 shares of Vera Therapeutics worth $1.22M as of Q1 2024.
  • Credit Suisse bought 8,317 Vera Therapeutics shares in Q1 2024, an estimated $296K.
  • Vera Therapeutics made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2149 holding.
  • Credit Suisse first reported a position in Vera Therapeutics in Q2 2022 and has held it in 6 quarters since.
  • 160 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.